Table: begin end state 1 17 cytoplasmic 18 36 transmembrane 37 41 non-cytoplasmic 42 60 transmembrane 61 71 cytoplasmic 72 89 transmembrane 90 100 non-cytoplasmic 101 118 transmembrane 119 124 cytoplasmic 125 144 transmembrane 145 173 non-cytoplasmic 174 192 transmembrane 193 271 cytoplasmic 272 292 transmembrane 293 297 non-cytoplasmic 298 316 transmembrane 317 336 cytoplasmic 337 356 transmembrane 357 361 non-cytoplasmic 362 383 transmembrane 384 394 cytoplasmic 395 428 transmembrane 429 447 non-cytoplasmic 448 479 transmembrane 480 485 cytoplasmic 486 507 transmembrane 508 509 non-cytoplasmic 510 512 transmembrane 513 527 non-cytoplasmic 528 529 transmembrane 530 532 non-cytoplasmic 533 556 transmembrane 557 565 cytoplasmic 566 586 transmembrane 587 597 non-cytoplasmic 598 617 transmembrane 618 627 cytoplasmic 628 646 transmembrane 647 650 non-cytoplasmic 651 667 transmembrane 668 675 cytoplasmic
Input: >Pf6N2E2_320 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_320 MSEDQHGIATDPRDWPKTLFYVALLFSIFQIVTAAFSPVSSIVLRAVHVGFLLWVVFLSY PAHGRQRPWQPLAWVLSLGGVATALYQWVFESDLIQRSGDLTTTDMIMGIVLVVLVFEAA RRVMGIALPIICGLFLAYGLFGEYLPGDLAHRGYGLDQIINQLSFGTEGLYGTPTYVSAT YIFLFILFGAFLEKAGMIKLFTDFAMGLFGHKLGGPAKVAVVSSALMGTITGSGIANVVT TGQFTIPLMKRFGYKAAFAGGVEATSSMGSQIMPPVMGAVAFIMAETINVPFVEIAKAAL IPACLYFGSVFWMVHLEAKRSDLKGLPKDQCPSAWGAVKDSWFLLIPLGVLVYLLFSGRT PLFSGMVGLALTAIVILGSAIILKVSNYALRCAFWIALGLLCVGFFRLGIGVVFAVIGVL VVACWFMQGTRETLVICLHALVDGARHAVPVGIACALVGSIIAVVSLTGVASTFAGYILA IGRDNLLLSLILTMLTCLVLGMGIPTIPNYIITSSIAAPALLELGVPLIVSHMFVFYFGI LADLTPPVALACFAAAPIARESGLKISFWAVRIALAGFVIPFMTVYNPALMLQGDNLWMT AYMLIKTLLAVGLWGMASTGYLQQKMPIWERLLCFAAGALLVVALPVTDEIGFVLGGLLI LQHVWRARRSGRALA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server